This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ScottsMiracle-Gro (SMG) Lowers Hawthorne Sales and EPS Outlook
by Zacks Equity Research
ScottsMiracle-Gro (SMG) projects Hawthorne sales to fall 15-25%, including the benefit of acquisitions, led by an oversupply of cannabis.
Scotts Miracle-Gro (SMG) Q1 Earnings Lag Estimates, Sales Beat
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) Q1 results are impacted by lower sales in the U.S. Consumer and Hawthorne segments.
Scotts Miracle-Gro (SMG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of -8.64% and 2.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why The Scotts Miracle-Gro (SMG) Might Surprise This Earnings Season
by Zacks Equity Research
The Scotts Miracle-Gro (SMG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Scotts Miracle-Gro (SMG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Scotts (SMG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ScottsMiracle-Gro (SMG) Buys Luxx Lighting & True Liberty Bags
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) Luxx Lighting buyout considerably strengthens The Hawthorne Gardening Company's industry-leading lighting portfolio.
ScottsMiracle-Gro (SMG) Puts Out Senior Notes Exchange Offer
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) exchange offer is made to fulfill the company's obligations per a registration rights agreement.
Scotts Miracle-Gro (SMG) Patents its Gavita CT 1930e LED Light
by Zacks Equity Research
Scotts Miracle-Gro (SMG) subsidiary's issue of patents is a testament to the revolutionary design and performance of the Gavita CT 1930e.
Scotts Miracle-Gro (SMG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Scotts Miracle-Gro (SMG) closed at $153.51, marking a +0.88% move from the previous day.
Scotts Miracle-Gro (SMG) Stock Moves -0.57%: What You Should Know
by Zacks Equity Research
Scotts Miracle-Gro (SMG) closed at $151.06 in the latest trading session, marking a -0.57% move from the prior day.
Scotts (SMG) Down 14.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Scotts (SMG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Scotts Miracle-Gro (SMG) Beats Q4 Earnings & Sales Estimates
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) Q4 results are impacted by lower sales in all the segments.
Scotts Miracle-Gro (SMG) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 3.53% and 9.49%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Scotts Miracle-Gro (SMG) in Q4 Earnings?
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) Q4 results are likely to reflect growth in Hawthorne business and higher costs.
Analysts Estimate Scotts Miracle-Gro (SMG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Scotts (SMG) Down 1.6% Since Last Earnings Report?
by Zacks Equity Research
Scotts (SMG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ScottsMiracle-Gro (SMG) Buys Rhizoflora Assets, Boosts Portfolio
by Nidhisha Chaudhary
ScottsMiracle-Gro (SMG) will substantially acquire all the assets of Rhizoflora for $33.5 million, which will add roughly $8 million to annualized sales.
Scotts Miracle-Gro (SMG) Beats Q3 Earnings and Sales Estimates
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) Q3 results benefit from record sales in the Hawthorne segment with growth in all categories.
Scotts Miracle-Gro (SMG) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 13.71% and 6.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, Home Depot, Lowe's and RH
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, Home Depot, Lowe's and RH
Buy This Stock Down 30% Before Earnings for Marijuana Growth?
by Benjamin Rains
Let's quickly dive into SMG stock ahead of its upcoming Q3 earnings report on August 4 to see if it might be worth buying...
Scotts Miracle-Gro (SMG) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) Q3 performance is likely to have benefited from higher demand in its U.S. Consumer and Hawthorne businesses.
Earnings Preview: Scotts Miracle-Gro (SMG) Q3 Earnings Expected to Decline
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Scotts (SMG) Down 16.2% Since Last Earnings Report?
by Zacks Equity Research
Scotts (SMG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Forget Meme Stocks: Buy These Strong Growth Stocks with Big Upside
by Benjamin Rains
Investors might want to consider adding growth focused stocks to their portfolios that are still trading below their highs, even as the meme stocks soar once again...